Wednesday 26 March 2025 06:42 GMT

UBS Among Leading Non-US Investors In Nuclear Weapons Producers, Says Study


(MENAFN- Swissinfo) The number of financial institutions funding major nuclear weapons manufacturers continues to fall, a new report shows. The Swiss bank UBS bank is one of the top 30 investors.

This content was published on February 18, 2025 - 11:37 2 minutes Keystone-SDA
  • Français fr UBS épinglée pour le financement de fabricants d'armes nucléaires Original Read more: UBS épinglée pour le financement de fabricants d'armes nucléaire

+Get the most important news from Switzerland in your inbox

UBS has injected close to $2.5 billion (CHF2.2 billion) in the form of shares or bonds, according to a report published by the Geneva-based International Campaign to Abolish Atomic Weapons (ICAN). UBS was the 9th biggest non-US investor. The Swiss bank also granted loans or subscriptions worth over $3 billion.

Last year, a total of 260 institutions had financing or investment relations with one or more of the 24 nuclear weapon producing companies. This figure has fallen by 27 over the space of one year, and by more than 70 since the Treaty on the Prohibition of Nuclear Weapons came into force in 2021. Loans also fell by $6 billion to under $270 billion.

More More Major Swiss banks invest billions in weapons manufacturers

This content was published on Nov 16, 2020 The major Swiss investment institutions invest millions in the global arms trade. An initiative wants to put an end to it.

Read more: Major Swiss banks invest billions in weapons manufacturer

This situation“shows the power of the treaty to make these inhumane and indiscriminate weapons inhuman”, according to ICAN Executive Director Melissa Parke. Despite this, the value of holdings or bonds in the main nuclear weapons manufacturers rose to $513 billion.

MENAFN18022025000210011054ID1109220968


Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.

Search